Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist

Ronald G. Tilton, Christy L. Munsch, Sidney J. Sherwood, Shi Juan Chen, Yiu Fai Chen, Chengda Wu, Natalie Block, Richard A.F. Dixon, Tommy A. Brock

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds